Hendrick Center for Research
Hendrick Center for Research provides the development and oversight to safely and effectively conduct research across a variety of specialty areas. To help advance healthcare, Hendrick offers phase 3 clinical trials and phase 4 observation trials, gaining early access to new technology, medications and devices for improving patient outcomes. Our goal is to make research studies and trials more accessible to the diverse communities we serve.
Overseen by a committee of individuals charged with reviewing and monitoring biomedical research involving human subjects, Hendrick Center for Research works under FDA and U.S. Department of Health and Human Services (HHS) regulations.
Hendrick current research areas:
- Cardiology
- Infectious Disease
- Rheumatology
- Surgical
- Oncology (Breast, Pancreatic, Colorectal, Lung)
Institutional Review Board Members
| Name | Role |
|---|---|
| Dr. Joji Varghese | Committee Chair |
| Dr. Joshua Reed | Clinical Member |
| Dr. Mustapha Khalife | Clinical Oncologist |
| Emily Goolsby | Clinical Member |
| Irene Labeck, PharmD | Scientist/Pharmacist |
| Bruce Lampert | Chaplain |
| Sabrina Williams | Community Liaison |
| Danielle Goss | Co-Chair/Non-voting member |
| Susan Greenwood, BSN, RN, VP | Non-voting member |
| David Evans, Esp., VP | Non-voting member |
| Anita Broxson | Community Liaison |
| Donna Jennings | Compliance |
| Sharn Devun | Risk Management |
To download the Hendrick Institutional Review Board application, click here.